Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.3 trillion and total revenue of $115.85 billion.
Market Cap
1.3T
Revenue
115.85B
Profits
-38.04B
PE Ratio
n/a
Profit Margin
-32.83%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.40B | 1.17% | 941,057 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.49B | -0.72% | 602,654 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 77.78B | 6.98% | 16,605,462 | 2.23B |
| 4 | ARGX | argenx SE | 59.35B | 1.73% | 323,723 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 42.84B | 4.78% | 4,066,873 | - |
| 6 | ONC | BeOne Medicines AG | 40.93B | -1.38% | 472,852 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.52B | 1.11% | 2,019,406 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.40B | 1.25% | 933,738 | 4.80B |
| 9 | INSM | Insmed Incorporated | 26.54B | 2.71% | 2,233,625 | 1.14B |
| 10 | ROIV | Roivant Sciences Ltd. | 26.10B | -1.87% | 5,659,882 | 7.53M |
| 11 | INCY | Incyte Corporation | 25.22B | -0.16% | 1,404,536 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.93B | 0.81% | 803,581 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.61B | 0.23% | 2,514,937 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.34B | 0.60% | 551,319 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 15.15B | 3.39% | 1,165,643 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.36B | 2.15% | 1,925,761 | 2.44B |
| 17 | HALO | Halozyme Therapeutics, Inc. | 13.08B | 2.47% | 3,172,136 | 1.66B |
| 18 | SMMT | Summit Therapeutics Inc. | 13.07B | -0.43% | 5,045,332 | - |
| 19 | BBIO | BridgeBio Pharma, Inc. | 12.96B | 0.87% | 4,271,702 | 713.07M |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.81B | 4.93% | 983,632 | 830.81M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.88B | -1.38% | 1,659,446 | 3.41B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.86B | 0.04% | 219,344 | 1.28B |
| 23 | TWST | Twist Bioscience Corporation | 11.54B | 16.11% | 3,535,195 | 431.80M |
| 24 | TECH | Bio-Techne Corporation | 11.38B | 0.07% | 2,986,242 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.27B | 1.33% | 386,176 | 776.57M |
| 26 | KRYS | Krystal Biotech, Inc. | 10.21B | 0.94% | 222,508 | 440.48M |
| 27 | KYMR | Kymera Therapeutics, Inc. | 9.63B | 0.29% | 841,723 | 105.00M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.33B | -1.33% | 1,626,385 | 669.50M |
| 29 | IBRX | ImmunityBio, Inc. | 9.16B | 0.12% | 8,980,028 | 165.79M |
| 30 | CYTK | Cytokinetics, Incorporated | 9.13B | -0.23% | 1,836,857 | 67.67M |
| 31 | CAI | Caris Life Sciences, Inc. | 9.12B | 1.96% | 5,982,290 | 989.61M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 8.89B | -0.98% | 989,225 | 281.99M |
| 33 | PCVX | Vaxcyte, Inc. | 8.47B | 0.71% | 1,852,006 | - |
| 34 | TGTX | TG Therapeutics, Inc. | 8.16B | 2.71% | 1,138,355 | 799.54M |
| 35 | ABVX | ABIVAX Société Anonyme | 8.07B | 0.79% | 1,663,244 | 5.33M |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 7.87B | -0.12% | 535,507 | 7.46M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.68B | -1.22% | 1,729,587 | - |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.28B | -0.27% | 6,448,796 | 874.09M |
| 39 | IMVT | Immunovant, Inc. | 7.02B | -1.56% | 1,479,998 | - |
| 40 | BLTE | Belite Bio, Inc | 6.82B | 0.46% | 218,955 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.77B | 0.07% | 730,812 | 239.92M |
| 42 | CGON | CG Oncology, Inc. | 6.09B | -6.27% | 1,444,251 | 6.23M |
| 43 | LGND | Ligand Pharmaceuticals Incorporated | 5.96B | 0.21% | 210,276 | 290.54M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.92B | -2.49% | 2,028,237 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.80B | 0.04% | 681,433 | 618.07M |
| 46 | TVTX | Travere Therapeutics, Inc. | 5.71B | 1.32% | 1,756,270 | 591.33M |
| 47 | ORKA | Oruka Therapeutics, Inc. | 5.66B | -4.94% | 1,294,406 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.46B | 0.06% | 2,591,472 | - |
| 49 | CRSP | CRISPR Therapeutics AG | 5.39B | -0.11% | 1,555,622 | 13.39M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.20B | -0.10% | 1,754,258 | 1.01B |
| 51 | ERAS | Erasca, Inc. | 5.08B | 4.09% | 6,266,869 | - |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.07B | -2.92% | 726,361 | 1.90M |
| 53 | DFTX | Definium Therapeutics, Inc. | 4.94B | -2.44% | 2,308,995 | - |
| 54 | IOVA | Iovance Biotherapeutics, Inc. | 4.89B | 5.99% | 11,926,877 | 324.97M |
| 55 | MANE | Veradermics, Incorporated | 4.83B | -0.05% | 580,775 | - |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.47B | 0.27% | 1,378,746 | - |
| 57 | VKTX | Viking Therapeutics, Inc. | 4.29B | -11.76% | 28,707,296 | - |
| 58 | TNGX | Tango Therapeutics, Inc. | 4.15B | 0.74% | 2,290,589 | 53.81M |
| 59 | ABCL | AbCellera Biologics Inc. | 4.10B | 2.76% | 4,990,522 | 66.17M |
| 60 | PBLS | Parabilis Medicines, Inc. | 4.01B | -2.52% | 1,166,153 | 148.00K |
| 61 | RLAY | Relay Therapeutics, Inc. | 3.89B | -1.66% | 3,676,232 | 10.35M |
| 62 | CELC | Celcuity Inc. | 3.88B | -0.78% | 1,237,796 | - |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.82B | -12.78% | 6,761,624 | 1.14B |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.79B | 0.35% | 830,287 | 890.79M |
| 65 | LEGN | Legend Biotech Corporation | 3.69B | 3.31% | 1,780,758 | 1.27B |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.69B | 4.10% | 3,113,951 | 7.50M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | -1.92% | 1,273,617 | 234.13M |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.33B | 2.25% | 598,792 | 606.33M |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.31B | -2.00% | 749,360 | - |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | -0.42% | 2,177,537 | 463.98M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.27B | 0.05% | 2,273,111 | 3.60M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.19B | -5.04% | 2,038,434 | 117.00M |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.08B | 1.73% | 3,197,693 | - |
| 74 | ZLAB | Zai Lab Limited | 2.84B | -4.39% | 585,281 | 449.61M |
| 75 | PGEN | Precigen, Inc. | 2.76B | 3.49% | 4,617,865 | 85.72M |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 2.72B | 0.26% | 1,824,214 | 7.12M |
| 77 | MBX | MBX Biosciences, Inc. | 2.67B | -4.32% | 638,966 | - |
| 78 | QURE | uniQure N.V. | 2.66B | -10.38% | 4,237,572 | 18.67M |
| 79 | GPCR | Structure Therapeutics Inc. | 2.57B | 0.19% | 2,110,907 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.55B | 0.53% | 455,568 | - |
| 81 | IMNM | Immunome, Inc. | 2.54B | -7.84% | 2,697,409 | 4.02M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.47B | 1.16% | 2,297,688 | 158.00K |
| 83 | BEAM | Beam Therapeutics Inc. | 2.46B | 1.19% | 2,284,237 | 156.04M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.45B | -0.96% | 2,023,123 | 36.77M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.42B | 3.99% | 4,652,594 | - |
| 86 | VERA | Vera Therapeutics, Inc. | 2.40B | 0.88% | 1,691,471 | - |
| 87 | HRMY | Harmony Biosciences Holdings, Inc. | 2.40B | 1.68% | 906,463 | 959.90M |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | -1.12% | 895,397 | - |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.34B | -3.59% | 2,211,441 | 71.13M |
| 90 | PHVS | Pharvaris N.V. | 2.32B | -0.24% | 949,002 | - |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 1.19% | 809,430 | 311.51M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.16B | -1.80% | 1,864,662 | 52.06M |
| 93 | ADMA | ADMA Biologics, Inc. | 2.13B | -1.86% | 2,586,548 | 512.28M |
| 94 | PVLA | Palvella Therapeutics, Inc. | 2.10B | -2.33% | 185,057 | - |
| 95 | TRVI | Trevi Therapeutics, Inc. | 2.09B | 1.49% | 1,697,254 | - |
| 96 | RXRX | Recursion Pharmaceuticals, Inc. | 2.09B | 5.14% | 19,338,253 | 54.86M |
| 97 | KOD | Kodiak Sciences Inc. | 2.08B | 5.39% | 1,290,834 | - |
| 98 | GENB | Generate Biomedicines, Inc. | 2.05B | -3.21% | 1,438,136 | 26.48M |
| 99 | NKTR | Nektar Therapeutics | 2.03B | 2.98% | 2,798,384 | 54.59M |
| 100 | URGN | UroGen Pharma Ltd. | 2.02B | -0.96% | 1,074,358 | 188.73M |
| 101 | VCEL | Vericel Corporation | 2.01B | 1.31% | 351,977 | 306.30M |
| 102 | NUVB | Nuvation Bio Inc. | 2.01B | 0.35% | 5,705,780 | 169.90M |
| 103 | BHVN | Biohaven Ltd. | 1.99B | -3.51% | 3,025,721 | - |
| 104 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.99B | 3.80% | 2,392,706 | 208.78M |
| 105 | LKFT | Lakefront Biotherapeutics NV | 1.97B | -1.17% | 435,336 | 1.13B |
| 106 | MESO | Mesoblast Limited | 1.97B | 1.24% | 236,792 | 120.25M |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | -3.77% | 1,635,130 | 98.34M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.94B | -2.96% | 2,562,081 | 1.97B |
| 109 | FTRE | Fortrea Holdings Inc. | 1.90B | 2.56% | 1,225,780 | 2.68B |
| 110 | ZYME | Zymeworks Inc. | 1.90B | -2.51% | 752,934 | 37.13M |
| 111 | VIR | Vir Biotechnology, Inc. | 1.81B | -3.34% | 2,085,371 | 303.23M |
| 112 | ZBIO | Zenas BioPharma, Inc. | 1.79B | -7.19% | 963,039 | 1.00M |
| 113 | SEPN | Septerna, Inc. | 1.78B | -0.83% | 293,141 | 98.88M |
| 114 | XNCR | Xencor, Inc. | 1.78B | -1.57% | 952,643 | 104.97M |
| 115 | ABSI | Absci Corporation | 1.78B | 6.10% | 3,388,022 | 1.56M |
| 116 | NVAX | Novavax, Inc. | 1.75B | 0.47% | 4,353,248 | 413.80M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.70B | -1.38% | 4,809,358 | 59.51M |
| 118 | KRSA | Korsana Biosciences, Inc. | 1.69B | 15.14% | 411,347 | - |
| 119 | GHRS | GH Research PLC | 1.68B | -5.82% | 418,311 | - |
| 120 | COAG | Hemab Therapeutics Holdings, Inc. | 1.67B | -2.75% | 401,283 | - |
| 121 | STOK | Stoke Therapeutics, Inc. | 1.63B | -3.14% | 1,220,367 | 27.59M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.62B | -0.88% | 848,742 | 20.00M |
| 123 | NBTX | Nanobiotix S.A. | 1.61B | -5.05% | 203,165 | 38.27M |
| 124 | IMCR | Immunocore Holdings plc | 1.61B | -0.79% | 640,553 | 430.78M |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.60B | 1.87% | 2,068,736 | 252.25M |
| 126 | TSHA | Taysha Gene Therapies, Inc. | 1.56B | -2.44% | 6,404,639 | 5.49M |
| 127 | KLRA | Kailera Therapeutics, Inc. | 1.55B | -8.76% | 2,762,261 | - |
| 128 | ANAB | AnaptysBio, Inc. | 1.55B | 1.83% | 418,398 | 106.09M |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.54B | -3.53% | 1,090,085 | - |
| 130 | BRVE | Braveheart Bio, Inc. | 1.53B | 8.90% | 396,722 | - |
| 131 | INVA | Innoviva, Inc. | 1.49B | 2.08% | 1,368,075 | 440.00M |
| 132 | AVBP | ArriVent BioPharma, Inc. | 1.48B | -0.66% | 608,957 | - |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.48B | 0.07% | 285,795 | 1.30M |
| 134 | OMER | Omeros Corporation | 1.46B | -2.94% | 909,691 | 38.42M |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.46B | -6.69% | 789,249 | 20.00M |
| 136 | RARE | Ultragenyx Pharmaceutical Inc. | 1.45B | -0.74% | 3,493,112 | 717.00M |
| 137 | ORIC | ORIC Pharmaceuticals, Inc. | 1.37B | -1.13% | 1,995,576 | - |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.36B | 1.72% | 468,685 | - |
| 139 | AAPG | Ascentage Pharma Group International | 1.36B | -2.25% | 15,439 | 94.61M |
| 140 | KARD | Kardigan, Inc. | 1.35B | -0.90% | 862,411 | - |
| 141 | BCAX | Bicara Therapeutics Inc. | 1.31B | -3.47% | 1,374,225 | - |
| 142 | SVRA | Savara Inc. | 1.29B | 1.40% | 2,499,762 | - |
| 143 | TRAX | First Tracks Biotherapeutics, Inc. | 1.28B | -2.26% | 1,144,149 | - |
| 144 | AVLN | Avalyn Pharma Inc. | 1.27B | -3.77% | 221,184 | - |
| 145 | DMRA | Damora Therapeutics, Inc. | 1.25B | -0.83% | 875,178 | - |
| 146 | LBRX | LB Pharmaceuticals Inc | 1.22B | -3.55% | 413,502 | - |
| 147 | REPL | Replimune Group, Inc. | 1.19B | -2.78% | 2,581,910 | - |
| 148 | LTGO | Latigo Biotherapeutics, Inc. | 1.18B | -11.07% | 340,766 | - |
| 149 | IMTX | Immatics N.V. | 1.14B | -3.14% | 2,372,896 | 47.65M |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.13B | -0.80% | 105,737 | - |
| 151 | AKTS | Aktis Oncology, Inc. | 1.09B | -0.46% | 384,968 | 10.06M |
| 152 | VOR | Vor Biopharma Inc. | 1.09B | -4.80% | 1,931,546 | - |
| 153 | ANRO | Alto Neuroscience, Inc. | 1.07B | -1.16% | 788,426 | - |
| 154 | MGTX | MeiraGTx Holdings plc | 1.06B | -5.96% | 1,605,305 | 397.50M |
| 155 | MNKD | MannKind Corporation | 1.06B | -1.50% | 2,964,535 | 393.63M |
| 156 | MLTX | MoonLake Immunotherapeutics | 1.03B | -6.05% | 1,901,879 | - |
| 157 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.97% | 1,302,054 | 24.00M |
| 158 | ANL | Adlai Nortye Group Ltd. | 1.02B | 0.51% | 144,263 | 18.06M |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 999.87M | -1.43% | 1,143,788 | 28.73M |
| 160 | CGEM | Cullinan Therapeutics, Inc. | 993.64M | -8.48% | 2,728,967 | - |
| 161 | CRVS | Corvus Pharmaceuticals, Inc. | 992.63M | -5.90% | 1,143,026 | - |
| 162 | KURA | Kura Oncology, Inc. | 966.11M | -1.63% | 1,772,167 | 77.23M |
| 163 | ABUS | Arbutus Biopharma Corporation | 965.50M | 0.62% | 6,262,979 | 181.72M |
| 164 | ODTX | Odyssey Therapeutics, Inc. | 955.01M | -4.00% | 396,000 | 99.00K |
| 165 | ALMS | Alumis Inc. | 943.58M | -2.02% | 2,605,339 | 7.40M |
| 166 | JBIO | Jade Biosciences, Inc. | 936.79M | 0.14% | 1,051,329 | - |
| 167 | SGP | SpyGlass Pharma, Inc. | 924.84M | -1.81% | 81,364 | - |
| 168 | HELP | Cybin Inc. | 919.83M | -3.30% | 1,459,104 | - |
| 169 | APMD | Apnimed, Inc. | 900.47M | -3.82% | 398,392 | 115.12M |
| 170 | RIGL | Rigel Pharmaceuticals, Inc. | 894.58M | -0.50% | 143,825 | 276.79M |
| 171 | SLBT | SL Science Holding Limited | 889.62M | -6.02% | 84,312 | 3.27M |
| 172 | SANA | Sana Biotechnology, Inc. | 886.11M | -3.90% | 3,509,293 | - |
| 173 | CADL | Candel Therapeutics, Inc. | 883.79M | 2.30% | 883,107 | - |
| 174 | ARDX | Ardelyx, Inc. | 859.70M | -0.86% | 3,233,585 | 450.89M |
| 175 | AVTX | Avalo Therapeutics, Inc. | 843.06M | 2.75% | 1,897,032 | 59.00K |
| 176 | IMMX | Immix Biopharma, Inc. | 837.01M | -1.85% | 1,535,833 | - |
| 177 | ATTO | Attovia Therapeutics, Inc. | 829.48M | -1.89% | 394,196 | 1.80M |
| 178 | OBX | Obsidian Therapeutics, Inc. | 828.37M | -12.12% | 426,631 | - |
| 179 | LXRX | Lexicon Pharmaceuticals, Inc. | 827.62M | -9.71% | 4,441,761 | 41.47M |
| 180 | FDMT | 4D Molecular Therapeutics, Inc. | 812.64M | -1.93% | 1,768,229 | 92.01M |
| 181 | GERN | Geron Corporation | 809.52M | 1.61% | 6,413,405 | 204.56M |
| 182 | ACHV | Achieve Life Sciences, Inc. | 805.73M | - | 1,141,096 | - |
| 183 | SLDB | Solid Biosciences Inc. | 802.04M | -6.73% | 1,349,278 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 791.93M | 2.28% | 2,488,961 | 8.22M |
| 185 | OLMA | Olema Pharmaceuticals, Inc. | 790.98M | 2.38% | 1,486,203 | - |
| 186 | WVE | Wave Life Sciences, Inc. | 780.31M | 0.25% | 3,155,949 | 65.37M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 777.23M | -0.95% | 327,689 | 109.82M |
| 188 | DSGN | Design Therapeutics, Inc. | 766.00M | -0.97% | 459,743 | - |
| 189 | FTH | Faeth Therapeutics, Inc. | 750.66M | -7.92% | 608,165 | - |
| 190 | IVA | Inventiva S.A. | 742.74M | -5.51% | 2,370,670 | 7.94M |
| 191 | ETRA | Electra Therapeutics, Inc. | 741.91M | -6.71% | 445,166 | - |
| 192 | PHAR | Pharming Group N.V. | 734.34M | -3.06% | 31,867 | 366.48M |
| 193 | ANNX | Annexon, Inc. | 720.40M | -1.81% | 2,022,864 | - |
| 194 | VSTM | Verastem, Inc. | 706.39M | -4.65% | 1,844,644 | 87.53M |
| 195 | NVCT | Nuvectis Pharma, Inc. | 704.74M | 2.66% | 258,188 | - |
| 196 | OABI | OmniAb, Inc. | 696.42M | - | 1,044,897 | 38.46M |
| 197 | DNA | Ginkgo Bioworks Holdings, Inc. | 690.24M | 19.46% | 4,029,650 | 132.42M |
| 198 | MDXG | MiMedx Group, Inc. | 686.53M | -1.26% | 1,021,805 | 355.17M |
| 199 | CLYM | Climb Bio, Inc. | 682.92M | -5.03% | 1,871,563 | - |
| 200 | SLN | Silence Therapeutics plc | 675.55M | -2.52% | 691,390 | 615.00K |
| 201 | DBVT | DBV Technologies S.A. | 673.51M | -4.68% | 333,464 | 5.04M |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 668.66M | -0.53% | 593,987 | 136.07M |
| 203 | BLSM | BlossomHill Therapeutics, Inc. | 650.64M | -8.37% | 263,552 | - |
| 204 | AURA | Aura Biosciences, Inc. | 637.78M | 2.16% | 963,076 | - |
| 205 | STTK | Shattuck Labs, Inc. | 633.29M | -0.79% | 1,428,689 | 1.00M |
| 206 | NGNE | Neurogene Inc. | 625.36M | 1.03% | 374,883 | 925.00K |
| 207 | CBIO | Crescent Biopharma, Inc. | 609.49M | 0.35% | 568,819 | 11.88M |
| 208 | CRMD | CorMedix Inc. | 605.63M | 1.04% | 946,581 | 462.25M |
| 209 | CTMX | CytomX Therapeutics, Inc. | 599.22M | -1.08% | 3,081,504 | 18.30M |
| 210 | MPLT | MapLight Therapeutics, Inc. | 597.99M | -0.09% | 342,633 | - |
| 211 | MNPR | Monopar Therapeutics Inc. | 596.31M | -0.60% | 252,917 | - |
| 212 | ALT | Altimmune, Inc. | 591.33M | -4.70% | 3,685,835 | 31.00K |
| 213 | OCS | Oculis Holding AG | 580.90M | -5.81% | 209,251 | 1.45M |
| 214 | ALLO | Allogene Therapeutics, Inc. | 576.97M | - | 7,791,092 | 4.64M |
| 215 | VALN | Valneva SE | 576.10M | -2.05% | 51,758 | 163.30M |
| 216 | SGMT | Sagimet Biosciences Inc. | 566.27M | -12.57% | 3,723,698 | - |
| 217 | PHAT | Phathom Pharmaceuticals, Inc. | 562.37M | 1.29% | 1,424,567 | 239.66M |
| 218 | PRME | Prime Medicine, Inc. | 546.17M | -1.92% | 4,485,368 | 4.07M |
| 219 | DRUG | Bright Minds Biosciences Inc. | 545.71M | -7.61% | 129,658 | - |
| 220 | EPRX | Eupraxia Pharmaceuticals Inc. | 535.72M | 0.25% | 452,919 | - |
| 221 | INDP | Indaptus Therapeutics, Inc. | 532.97M | 6.10% | 516,796 | - |
| 222 | AGMB | AgomAb Therapeutics NV | 521.04M | -1.76% | 64,174 | - |
| 223 | ARVN | Arvinas, Inc. | 509.36M | -0.51% | 1,218,009 | 316.70M |
| 224 | AUTL | Autolus Therapeutics plc | 508.37M | -2.05% | 1,819,212 | 117.39M |
| 225 | PROK | ProKidney Corp. | 507.90M | 1.82% | 1,726,690 | 818.00K |
| 226 | PBYI | Puma Biotechnology, Inc. | 506.91M | 5.82% | 467,561 | 231.24M |
| 227 | CAPR | Capricor Therapeutics, Inc. | 498.25M | -1.15% | 2,402,139 | 11.13M |
| 228 | OVID | Ovid Therapeutics Inc. | 487.27M | -2.92% | 1,528,465 | 1.58M |
| 229 | ENTX | Entera Bio Ltd. | 484.80M | -0.36% | 234,001 | 42.00K |
| 230 | ASMB | Assembly Biosciences, Inc. | 481.73M | -1.29% | 179,020 | 74.85M |
| 231 | RGNX | REGENXBIO Inc. | 477.94M | -3.47% | 1,516,275 | 174.48M |
| 232 | TECX | Tectonic Therapeutic, Inc. | 471.53M | -3.44% | 214,413 | - |
| 233 | CTNM | Contineum Therapeutics, Inc. | 469.89M | -0.16% | 632,162 | - |
| 234 | EIKN | Eikon Therapeutics, Inc. | 449.03M | 1.97% | 710,106 | - |
| 235 | KYTX | Kyverna Therapeutics, Inc. | 432.29M | -1.13% | 3,277,189 | - |
| 236 | PRTA | Prothena Corporation plc | 427.12M | -4.15% | 426,063 | 54.53M |
| 237 | EDIT | Editas Medicine, Inc. | 422.35M | 2.23% | 2,590,491 | 47.01M |
| 238 | DMAC | DiaMedica Therapeutics Inc. | 422.24M | 3.57% | 209,248 | - |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 414.66M | -2.08% | 228,813 | - |
| 240 | RZLT | Rezolute, Inc. | 413.29M | -1.50% | 3,868,971 | - |
| 241 | SPRY | ARS Pharmaceuticals, Inc. | 412.71M | -0.72% | 1,052,648 | 116.93M |
| 242 | PRLD | Prelude Therapeutics Incorporated | 410.95M | -7.42% | 1,040,076 | 22.42M |
| 243 | SCTX | Scribe Therapeutics Inc. | 409.11M | -18.55% | 526,468 | 33.30M |
| 244 | RLMD | Relmada Therapeutics, Inc. | 406.41M | 0.79% | 1,325,333 | - |
| 245 | IRD | Opus Genetics, Inc. | 405.16M | 0.83% | 1,831,217 | 9.86M |
| 246 | ARCT | Arcturus Therapeutics Holdings Inc. | 401.33M | 6.17% | 1,502,771 | 29.37M |
| 247 | GALT | Galectin Therapeutics Inc. | 399.36M | -2.22% | 153,324 | - |
| 248 | ZURA | Zura Bio Limited | 398.65M | -3.93% | 3,433,302 | - |
| 249 | SRZN | Surrozen, Inc. | 395.86M | 108.42% | 11,526,993 | 11.51M |
| 250 | TTRX | Turn Therapeutics Inc. | 394.99M | -1.85% | 244,963 | - |
| 251 | AGEN | Agenus Inc. | 382.67M | 1.19% | 636,610 | 132.69M |
| 252 | IKT | Inhibikase Therapeutics, Inc. | 382.36M | -2.33% | 499,103 | 1.00 |
| 253 | VTVT | vTv Therapeutics Inc. | 381.81M | 0.49% | 18,029 | 36.84M |
| 254 | CCCC | C4 Therapeutics, Inc. | 372.77M | -1.62% | 2,807,558 | 35.04M |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 372.41M | 1.05% | 103,537 | 59.22M |
| 256 | ARTV | Artiva Biotherapeutics, Inc. | 366.19M | -2.98% | 511,723 | 251.00K |
| 257 | CABA | Cabaletta Bio, Inc. | 365.37M | -2.93% | 5,589,960 | - |
| 258 | VOGX | Vogenx, Inc. | 359.49M | -9.90% | 96,257 | - |
| 259 | OBIO | Orchestra BioMed Holdings, Inc. | 357.63M | 0.34% | 262,886 | 31.98M |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 349.50M | 0.42% | 206,241 | 65.26M |
| 261 | LRMR | Larimar Therapeutics, Inc. | 346.55M | -14.10% | 3,632,778 | - |
| 262 | OCGN | Ocugen, Inc. | 339.11M | - | 5,621,853 | 4.58M |
| 263 | YDES | YD Bio Limited | 337.87M | 47.68% | 3,172,039 | 1.24M |
| 264 | BNTC | Benitec Biopharma Inc. | 336.27M | -1.93% | 196,779 | - |
| 265 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 319.90M | -4.09% | 656,662 | - |
| 266 | EVMN | Evommune, Inc. | 319.37M | 0.34% | 992,272 | 10.00M |
| 267 | EYPT | EyePoint, Inc. | 314.67M | -1.88% | 2,301,754 | 2.79M |
| 268 | ABEO | Abeona Therapeutics Inc. | 310.51M | -1.81% | 852,416 | 25.52M |
| 269 | IPSC | Century Therapeutics, Inc. | 306.02M | -3.98% | 545,259 | 109.16M |
| 270 | SABS | SAB Biotherapeutics, Inc. | 304.80M | -1.18% | 544,277 | 114.70K |
| 271 | VNDA | Vanda Pharmaceuticals Inc. | 301.10M | -1.19% | 921,138 | 215.72M |
| 272 | XFOR | X4 Pharmaceuticals, Inc. | 297.44M | -3.54% | 973,684 | 15.85M |
| 273 | RCKT | Rocket Pharmaceuticals, Inc. | 295.29M | -10.93% | 4,384,224 | - |
| 274 | FULC | Fulcrum Therapeutics, Inc. | 288.79M | -0.66% | 1,948,350 | 80.00M |
| 275 | IFRX | InflaRx N.V. | 284.42M | -1.53% | 510,187 | -11.54K |
| 276 | CUVL | Clinuvel Pharmaceuticals Limited | 283.65M | -0.17% | 2,354 | 65.05M |
| 277 | UPB | Upstream Bio, Inc. | 283.17M | -0.39% | 566,582 | 3.16M |
| 278 | IMRX | Immuneering Corporation | 280.79M | -0.91% | 590,129 | - |
| 279 | FATE | Fate Therapeutics, Inc. | 279.18M | -4.12% | 1,178,682 | 6.49M |
| 280 | LXEO | Lexeo Therapeutics, Inc. | 278.12M | -3.69% | 1,485,054 | - |
| 281 | QTTB | Q32 Bio Inc. | 274.47M | -3.56% | 1,075,271 | 53.74M |
| 282 | PALI | Palisade Bio, Inc. | 273.60M | -1.88% | 3,257,886 | 500.00K |
| 283 | VCRE | Vicore Pharma Holding AB (publ) | 270.20M | 1.12% | 21,133 | 412.09K |
| 284 | IVVD | Invivyd, Inc. | 269.20M | -1.06% | 5,999,986 | 58.37M |
| 285 | GLSI | Greenwich LifeSciences, Inc. | 265.68M | 3.37% | 88,145 | - |
| 286 | ACIU | AC Immune SA | 264.48M | -6.01% | 265,288 | 21.67M |
| 287 | BCYC | Bicycle Therapeutics plc | 261.07M | 3.61% | 820,637 | 61.21M |
| 288 | STRO | Sutro Biopharma, Inc. | 260.49M | -0.13% | 252,896 | 45.70M |
| 289 | ZNTL | Zentalis Pharmaceuticals, Inc. | 260.35M | -4.18% | 1,174,546 | 26.87M |
| 290 | LYEL | Lyell Immunopharma, Inc. | 247.99M | -3.89% | 164,517 | 27.00K |
| 291 | PYXS | Pyxis Oncology, Inc. | 243.55M | -9.32% | 879,402 | 11.04M |
| 292 | YARW | Yarrow Bioscience, Inc. | 242.56M | -6.49% | 183,899 | - |
| 293 | MGNX | MacroGenics, Inc. | 242.06M | - | 571,448 | 175.14M |
| 294 | PRQR | ProQR Therapeutics N.V. | 241.32M | 0.59% | 604,378 | 21.05M |
| 295 | CAMP | Camp4 Therapeutics Corporation | 240.97M | 3.23% | 130,349 | 4.22M |
| 296 | LCTX | Lineage Cell Therapeutics, Inc. | 239.71M | -0.93% | 2,439,912 | 13.08M |
| 297 | CUE | Cue Biopharma, Inc. | 238.64M | 3.60% | 330,396 | 37.66M |
| 298 | SION | Sionna Therapeutics, Inc. | 236.46M | -5.08% | 1,252,784 | - |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 230.55M | -3.18% | 205,771 | 1.48M |
| 300 | KROS | Keros Therapeutics, Inc. | 229.00M | -0.69% | 284,438 | 15.01M |
| 301 | CGEN | Compugen Ltd. | 224.50M | 1.28% | 111,365 | 74.00M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 224.27M | -4.31% | 319,118 | 4.69M |
| 303 | PLX | Protalix BioTherapeutics, Inc. | 221.57M | -1.79% | 302,700 | 80.62M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 220.05M | 1.05% | 245,788 | 7.15M |
| 305 | ELDN | Eledon Pharmaceuticals, Inc. | 217.99M | -1.47% | 1,029,659 | - |
| 306 | NGEN | NervGen Pharma Corp. | 217.20M | 3.06% | 317,136 | - |
| 307 | AVXL | Anavex Life Sciences Corp. | 216.91M | -0.43% | 937,053 | - |
| 308 | ALEC | Alector, Inc. | 214.38M | -4.95% | 849,547 | 13.86M |
| 309 | FHTX | Foghorn Therapeutics Inc. | 213.79M | -6.98% | 518,520 | 36.74M |
| 310 | CMPX | Compass Therapeutics, Inc. | 204.40M | -2.99% | 4,539,648 | 850.00K |
| 311 | NKTX | Nkarta, Inc. | 204.13M | 3.26% | 933,924 | - |
| 312 | ADAG | Adagene Inc. | 200.09M | 0.34% | 317,092 | 9.29M |
| 313 | VRXA | Veraxa Biotech AG | 199.39M | 1.44% | 23,522 | 29.54K |
| 314 | ORMP | Oramed Pharmaceuticals Inc. | 199.25M | 1.48% | 149,322 | 2.00M |
| 315 | SLGL | Sol-Gel Technologies Ltd. | 198.86M | 1.73% | 66,871 | 1.80M |
| 316 | TARA | Protara Therapeutics, Inc. | 197.97M | -5.37% | 661,971 | - |
| 317 | ALXO | ALX Oncology Holdings Inc. | 187.37M | -7.82% | 1,204,595 | - |
| 318 | ACOG | Alpha Cognition Inc. | 186.64M | -2.39% | 141,361 | 15.26M |
| 319 | PEPG | PepGen Inc. | 185.62M | -1.47% | 657,490 | - |
| 320 | MSLE | Satellos Bioscience Inc. | 185.05M | 3.57% | 40,972 | - |
| 321 | ANTX | AN2 Therapeutics, Inc. | 184.53M | 1.24% | 258,937 | - |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 184.06M | 3.12% | 476,139 | 1.50M |
| 323 | CHRS | Coherus Oncology, Inc. | 180.77M | -7.14% | 1,569,402 | 50.94M |
| 324 | MDWD | MediWound Ltd. | 178.55M | 1.32% | 61,093 | 11.86M |
| 325 | DTIL | Precision BioSciences, Inc. | 174.72M | -0.47% | 401,825 | 45.06M |
| 326 | VYGR | Voyager Therapeutics, Inc. | 172.53M | -2.44% | 1,094,800 | 34.46M |
| 327 | NBP | NovaBridge Biosciences | 168.20M | -5.23% | 831,817 | - |
| 328 | TNXP | Tonix Pharmaceuticals Holding Corp. | 166.36M | -5.27% | 614,799 | 29.10M |
| 329 | NERV | Minerva Neurosciences, Inc. | 164.73M | -1.15% | 147,504 | - |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 161.63M | -3.04% | 265,853 | - |
| 331 | OTLK | Outlook Therapeutics, Inc. | 159.65M | -0.89% | 2,780,154 | -1.16M |
| 332 | MENS | Jyong Biotech Ltd. | 159.60M | 0.47% | 56,130 | - |
| 333 | HUMA | Humacyte, Inc. | 157.98M | 0.53% | 2,835,496 | 2.12M |
| 334 | MOLN | Molecular Partners AG | 157.07M | - | - | 856.30K |
| 335 | IPHA | Innate Pharma S.A. | 154.46M | -3.41% | 17,692 | 11.21M |
| 336 | CDXS | Codexis, Inc. | 150.02M | -0.72% | 863,610 | 77.68M |
| 337 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 144.09M | -3.75% | 757,963 | - |
| 338 | KRRO | Korro Bio, Inc. | 140.92M | -2.64% | 197,457 | 2.38M |
| 339 | SPRB | Spruce Biosciences, Inc. | 140.88M | -0.81% | 85,779 | 697.00K |
| 340 | RNA | Atrium Therapeutics, Inc. | 140.10M | -1.68% | 355,242 | 35.84M |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 139.02M | -6.25% | 3,594,213 | 1.34M |
| 342 | ARMP | Armata Pharmaceuticals, Inc. | 134.60M | -0.55% | 144,441 | 5.54M |
| 343 | TLSA | Tiziana Life Sciences Ltd | 134.48M | -0.95% | 707,378 | - |
| 344 | KZIA | Kazia Therapeutics Limited | 134.02M | 1.87% | 561,146 | 1.27M |
| 345 | CRBU | Caribou Biosciences, Inc. | 134.01M | -3.10% | 978,905 | 10.04M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 133.98M | - | 660,307 | - |
| 347 | HURA | TuHURA Biosciences, Inc. | 133.83M | 2.44% | 194,490 | - |
| 348 | NMRA | Neumora Therapeutics, Inc. | 132.11M | -3.86% | 1,429,773 | - |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 131.09M | -4.11% | 681,053 | 3.39M |
| 350 | MNOV | MediciNova, Inc. | 130.44M | -5.36% | 452,913 | 920.48K |
| 351 | ENGN | enGene Therapeutics Inc. | 128.67M | -4.00% | 796,304 | - |
| 352 | IMUX | Immunic, Inc. | 127.17M | -0.53% | 448,523 | - |
| 353 | NAUT | Nautilus Biotechnology, Inc. | 126.05M | 3.84% | 518,808 | 190.00K |
| 354 | INO | Inovio Pharmaceuticals, Inc. | 125.11M | -3.20% | 2,853,260 | 65.34K |
| 355 | TVGN | Tevogen Inc. | 123.53M | 0.51% | 2,926 | - |
| 356 | COYA | Coya Therapeutics, Inc. | 121.51M | 2.78% | 106,635 | 8.02M |
| 357 | AARD | Aardvark Therapeutics, Inc. | 121.46M | -0.18% | 96,095 | - |
| 358 | OKUR | OnKure Therapeutics, Inc. | 118.65M | -0.34% | 149,717 | - |
| 359 | LENZ | LENZ Therapeutics, Inc. | 116.88M | -1.06% | 1,008,517 | 21.48M |
| 360 | CBUS | Cibus, Inc. | 114.64M | -2.60% | 81,802 | 4.35M |
| 361 | MIST | Milestone Pharmaceuticals Inc. | 112.01M | -7.78% | 2,325,135 | 2.34M |
| 362 | CNXU | Conexeu Sciences Inc. | 111.70M | -5.94% | 163,669 | - |
| 363 | VANI | Vivani Medical, Inc. | 110.95M | - | 80,189 | - |
| 364 | NTRB | Nutriband Inc. | 109.28M | 22.31% | 387,875 | 1.62M |
| 365 | EQ | Equillium, Inc. | 109.06M | -1.71% | 280,738 | 4.39M |
| 366 | GNLX | Genelux Corporation | 108.89M | -3.38% | 151,994 | 8.00K |
| 367 | PYPD | PolyPid Ltd. | 108.87M | 1.71% | 60,458 | - |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 108.59M | -0.53% | 460,230 | 70.00M |
| 369 | TENX | Tenax Therapeutics, Inc. | 108.26M | -0.53% | 4,080,062 | - |
| 370 | BMEA | Biomea Fusion, Inc. | 108.00M | 3.47% | 2,185,403 | - |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 106.67M | - | 28,138 | - |
| 372 | RANI | Rani Therapeutics Holdings, Inc. | 104.41M | -2.35% | 607,394 | 4.88M |
| 373 | PMN | ProMIS Neurosciences, Inc. | 103.76M | -10.59% | 52,696 | - |
| 374 | SEER | Seer, Inc. | 103.55M | 3.89% | 767,630 | 14.22M |
| 375 | PMVP | PMV Pharmaceuticals, Inc. | 100.81M | -2.55% | 486,346 | - |
| 376 | CLLS | Cellectis S.A. | 100.42M | -0.69% | 68,810 | 63.82M |
| 377 | CRDF | Cardiff Oncology, Inc. | 99.58M | -2.29% | 596,494 | 508.00K |
| 378 | NRXS | NeurAxis, Inc. | 97.32M | 6.02% | 117,375 | 5.32M |
| 379 | ANIX | Anixa Biosciences, Inc. | 96.64M | 1.09% | 257,675 | - |
| 380 | ACRV | Acrivon Therapeutics, Inc. | 90.85M | 2.91% | 317,067 | - |
| 381 | ICCC | ImmuCell Corporation | 90.55M | -0.20% | 2,126 | 30.68M |
| 382 | CGTX | Cognition Therapeutics, Inc. | 90.42M | 0.08% | 266,921 | - |
| 383 | ACET | Adicet Bio, Inc. | 89.02M | -2.59% | 358,549 | - |
| 384 | RLYB | Rallybio Corporation | 88.21M | -1.48% | 6,844 | 646.00K |
| 385 | ONCY | Oncolytics Biotech Inc. | 86.61M | 0.40% | 1,213,714 | - |
| 386 | PTHS | Pelthos Therapeutics Inc. | 85.76M | -4.76% | 17,446 | 43.30M |
| 387 | ATRA | Atara Biotherapeutics, Inc. | 85.72M | -0.23% | 20,777 | 6.19M |
| 388 | TELO | Telomir Pharmaceuticals, Inc. | 83.22M | -0.82% | 31,098 | - |
| 389 | NTHI | NeOnc Technologies Holdings, Inc. | 82.03M | 2.48% | 202,853 | 39.99K |
| 390 | GANX | Gain Therapeutics, Inc. | 80.30M | - | 407,685 | - |
| 391 | IBIO | iBio, Inc. | 77.17M | -3.61% | 378,017 | 100.00K |
| 392 | OSTX | OS Therapies Incorporated | 76.57M | 0.61% | 347,758 | - |
| 393 | FBIO | Fortress Biotech, Inc. | 76.04M | -2.56% | 203,679 | 68.47M |
| 394 | MAIA | MAIA Biotechnology, Inc. | 76.03M | -5.30% | 594,998 | - |
| 395 | RNXT | RenovoRx, Inc. | 75.82M | 3.07% | 630,067 | 1.98M |
| 396 | VRCA | Verrica Pharmaceuticals Inc. | 74.90M | -5.63% | 40,899 | 30.32M |
| 397 | GUTS | Fractyl Health, Inc. | 74.80M | -3.23% | 1,552,038 | 3.00K |
| 398 | ALDX | Aldeyra Therapeutics, Inc. | 73.60M | -9.63% | 838,697 | - |
| 399 | CING | Cingulate Inc. | 73.58M | 1.61% | 82,485 | - |
| 400 | KLRS | Kalaris Therapeutics, Inc. | 73.08M | -1.60% | 33,588 | - |
| 401 | SPRO | Spero Therapeutics, Inc. | 72.79M | -0.79% | 476,932 | 47.00M |
| 402 | OKYO | OKYO Pharma Limited | 72.42M | 4.55% | 87,147 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 70.59M | 1.33% | 398,028 | - |
| 404 | CNTB | Connect Biopharma Holdings Limited | 69.27M | 2.80% | 778,221 | 2.95M |
| 405 | BSEM | BioStem Technologies, Inc. | 69.26M | 2.11% | 150,500 | 34.59M |
| 406 | CSBR | Champions Oncology, Inc. | 68.90M | -1.39% | 3,708 | 60.66M |
| 407 | GOSS | Gossamer Bio, Inc. | 66.79M | -0.55% | 236,250 | 53.29M |
| 408 | ALPS | Alps Group Inc | 66.56M | - | 94,533 | 3.74M |
| 409 | XBIT | XBiotech Inc. | 65.85M | -0.92% | 24,001 | - |
| 410 | HYPD | Hyperion DeFi, Inc. | 64.80M | 6.38% | 631,393 | 1.40M |
| 411 | ELOX | Eloxx Pharmaceuticals, Inc. | 64.58M | 3.63% | 28,903 | - |
| 412 | ATHE | Alterity Therapeutics Limited | 64.24M | 6.20% | 5,815 | 2.50M |
| 413 | RNTX | Rein Therapeutics Inc. | 64.18M | -3.41% | 296,308 | - |
| 414 | HYFT | MindWalk Holdings Corp. | 64.07M | -2.16% | 119,025 | 11.57M |
| 415 | INKT | MiNK Therapeutics, Inc. | 62.77M | -0.40% | 9,981 | - |
| 416 | CLNN | Clene Inc. | 59.84M | -1.86% | 47,751 | 197.00K |
| 417 | XLO | Xilio Therapeutics, Inc. | 59.22M | 0.67% | 16,006 | 64.09M |
| 418 | BOLD | Boundless Bio, Inc. | 59.14M | -3.70% | 550,321 | - |
| 419 | EXOZ | eXoZymes, Inc. | 58.80M | -0.71% | 6,482 | -700.00 |
| 420 | ANVS | Annovis Bio, Inc. | 56.67M | 4.72% | 855,175 | - |
| 421 | INMB | INmune Bio Inc. | 55.51M | - | 167,874 | 50.00K |
| 422 | HRTX | Heron Therapeutics, Inc. | 55.06M | -0.34% | 929,846 | 151.18M |
| 423 | EDSA | Edesa Biotech, Inc. | 54.45M | 1.51% | 29,568 | - |
| 424 | SER | Serina Therapeutics, Inc. | 54.36M | -2.28% | 76,447 | 130.00K |
| 425 | MREO | Mereo BioPharma Group plc | 53.90M | -0.82% | 1,305,862 | 500.00K |
| 426 | IMA | ImageneBio, Inc. | 52.90M | -3.72% | 3,689 | 800.00K |
| 427 | APLM | Apollomics, Inc. | 51.56M | 0.34% | 1,309 | 8.84M |
| 428 | ELTX | Elicio Therapeutics, Inc. | 49.41M | 0.53% | 339,769 | - |
| 429 | LITS | Lite Strategy, Inc. | 48.66M | 21.19% | 5,371,412 | - |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 48.61M | -5.30% | 17,169 | - |
| 431 | TIL | Instil Bio, Inc. | 48.29M | -1.66% | 8,362 | - |
| 432 | IBO | Impact BioMedical Inc. | 48.27M | -14.78% | 23,370 | 35.00K |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 47.68M | -0.85% | 228,267 | 21.00M |
| 434 | LONA | LeonaBio, Inc. | 47.01M | -15.28% | 150,996 | - |
| 435 | GRCE | Grace Therapeutics, Inc. | 45.44M | 1.89% | 106,339 | - |
| 436 | PDSB | PDS Biotechnology Corporation | 44.78M | -2.89% | 6,097,352 | - |
| 437 | MGX | Metagenomi Therapeutics, Inc. | 43.44M | 1.77% | 211,649 | 13.56M |
| 438 | VERU | Veru Inc. | 42.80M | 2.03% | 87,409 | 16.89M |
| 439 | KPTI | Karyopharm Therapeutics Inc. | 39.24M | -1.14% | 677,356 | 146.62M |
| 440 | CELU | Celularity Inc. | 38.21M | 14.78% | 454,723 | 26.55M |
| 441 | CRVO | CervoMed Inc. | 38.10M | 0.40% | 91,009 | 331.30K |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 37.42M | 0.85% | 85,940 | 35.09M |
| 443 | FLNA | Filana Therapeutics, Inc. | 37.33M | -11.18% | 2,313,595 | - |
| 444 | IMMP | Immutep Limited | 37.21M | -1.54% | 241,326 | 13.79M |
| 445 | BCTX | BriaCell Therapeutics Corp. | 37.02M | 6.73% | 241,763 | - |
| 446 | MCRB | Seres Therapeutics, Inc. | 35.99M | -4.49% | 89,565 | 1.88M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 34.66M | -0.18% | 59,869 | 31.52M |
| 448 | CNTX | Context Therapeutics Inc. | 34.10M | -3.01% | 883,674 | - |
| 449 | ATYR | aTyr Pharma, Inc. | 33.11M | -10.02% | 130,119,574 | 190.00K |
| 450 | NNVC | NanoViricides, Inc. | 32.80M | -4.64% | 465,656 | - |
| 451 | QNTM | Quantum BioPharma Ltd. | 32.35M | 3.09% | 564,460 | - |
| 452 | QNRX | Quoin Pharmaceuticals, Ltd. | 30.65M | -5.48% | 39,531 | - |
| 453 | QNCX | Quince Therapeutics, Inc. | 30.51M | -0.50% | 10,862 | - |
| 454 | CVM | CEL-SCI Corporation | 30.25M | 2.38% | 56,131 | - |
| 455 | BYSI | BeyondSpring Inc. | 29.81M | -0.22% | 17,602 | 1.88M |
| 456 | IGC | IGC Pharma, Inc. | 29.06M | -1.75% | 333,266 | 1.11M |
| 457 | KYNB | Kyntra Bio, Inc. | 28.34M | -3.45% | 15,538 | 4.62M |
| 458 | ABVC | ABVC BioPharma, Inc. | 28.26M | -4.39% | 64,290 | 797.92K |
| 459 | RNAZ | TransCode Therapeutics, Inc. | 27.94M | -1.79% | 28,657 | - |
| 460 | EVAX | Evaxion A/S | 27.19M | -0.61% | 36,866 | 7.49M |
| 461 | GRDX | GridAI Technologies Corp. | 26.98M | -1.30% | 99,783 | - |
| 462 | PLRZ | Polyrizon Ltd. | 25.25M | -5.82% | 13,387 | - |
| 463 | RADX | Radiopharm Theranostics Limited | 24.34M | -3.27% | 59,942 | 9.34M |
| 464 | NXTC | NextCure, Inc. | 24.17M | 9.54% | 226,905 | - |
| 465 | TCRX | TScan Therapeutics, Inc. | 23.65M | -4.12% | 606,695 | 7.11M |
| 466 | PBM | Psyence Biomedical Ltd. | 22.35M | -7.13% | 137,650 | - |
| 467 | COCP | Cocrystal Pharma, Inc. | 22.15M | -3.36% | 48,044 | 330.00K |
| 468 | ESLA | Estrella Immunopharma, Inc. | 20.49M | -0.21% | 9,160 | - |
| 469 | ATOS | Atossa Therapeutics, Inc. | 20.46M | -5.96% | 37,461 | - |
| 470 | MRKR | Marker Therapeutics, Inc. | 19.84M | -4.03% | 141,641 | 3.55M |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 19.75M | -0.82% | 5,420 | 1.17M |
| 472 | CLRB | Cellectar Biosciences, Inc. | 19.61M | -0.72% | 55,487 | - |
| 473 | AKTX | Akari Therapeutics, Plc | 19.59M | 4.14% | 47,386 | - |
| 474 | JSPR | Jasper Therapeutics, Inc. | 19.48M | 3.28% | 634,404 | - |
| 475 | ALLR | Allarity Therapeutics, Inc. | 17.34M | 4.81% | 74,978 | 345.00K |
| 476 | LPCN | Lipocine Inc. | 17.23M | -1.42% | 32,639 | 1.57M |
| 477 | KTTA | Pasithea Therapeutics Corp. | 17.17M | 0.20% | 105,131 | - |
| 478 | PTN | Palatin Technologies, Inc. | 17.05M | -4.28% | 26,519 | 12.88M |
| 479 | KPRX | Kiora Pharmaceuticals, Inc. | 16.99M | 1.91% | 19,375 | 20.00K |
| 480 | NCEL | NewcelX Ltd. | 16.69M | 1.05% | 4,157 | - |
| 481 | BCDA | BioCardia, Inc. | 16.20M | 1.90% | 122,506 | 3.00K |
| 482 | CMMB | Chemomab Therapeutics Ltd. | 15.94M | -3.51% | 97,183 | - |
| 483 | DYAI | Dyadic International, Inc. | 15.86M | 4.89% | 122,466 | 3.80M |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 15.65M | 0.28% | 154,736 | 7.11M |
| 485 | LTRN | Lantern Pharma Inc. | 15.47M | -12.95% | 515,479 | - |
| 486 | PASG | Passage Bio, Inc. | 15.45M | -4.00% | 6,658 | - |
| 487 | ICU | SeaStar Medical Holding Corporation | 15.16M | -2.55% | 13,898 | 1.71M |
| 488 | ACTU | Actuate Therapeutics, Inc. | 14.89M | -15.25% | 273,379 | - |
| 489 | NIKI | Niki BioSolutions, Inc. | 14.60M | 6.20% | 26,965 | - |
| 490 | HIND | Vyome Holdings, Inc. | 14.46M | 2.49% | 6,333 | 129.73K |
| 491 | CNSY | Cerenome, Inc. | 14.19M | -4.10% | 86,042 | 4.20M |
| 492 | TVRD | Tvardi Therapeutics, Inc. | 14.14M | -19.70% | 609,625 | - |
| 493 | TPST | Tempest Therapeutics, Inc. | 14.06M | -7.81% | 447,178 | - |
| 494 | NRSN | NeuroSense Therapeutics Ltd. | 13.68M | - | 8,880 | - |
| 495 | LSTA | Lisata Therapeutics, Inc. | 13.52M | 4.53% | 25,475 | 100.00K |
| 496 | VTGN | Vistagen Therapeutics, Inc. | 13.09M | -19.92% | 20,471,724 | 2.50M |
| 497 | AEON | AEON Biopharma, Inc. | 12.98M | -1.40% | 561,668 | - |
| 498 | PLUR | Pluri Inc. | 12.96M | -0.94% | 14,469 | 1.02M |
| 499 | INTS | Intensity Therapeutics, Inc. | 12.70M | -5.12% | 10,590 | - |
| 500 | GTBP | GT Biopharma, Inc. | 12.32M | -3.80% | 28,216 | - |